trial · primary record
[203Pb]Pb-PSV359
Pancreatic Ductal Adenocarcinoma
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 112 |
| Primary completion | 2032-05-28 |
| Primary endpoint | Determination of safety and tolerability of [203Pb]Pb-PSV359 |
| Registry ID | NCT06710756 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:43:49.674Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06710756
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.